Current Therapeutic Strategies and Perspectives for Neuroprotection in Parkinson's Disease.

Ghanta, Mohan K; Elango, P; L V K S, Bhaskar

Ghanta, Mohan K; Elango, P; L V K S, Bhaskar.

Afiliação

Ghanta MK; Department of Pharmacology, Sri Ramachandra Medical College and Research Institute, Sri Ramachandra Institute of Higher Education and Research (DU), Porur, Chennai-600116, Tamil Nadu, India.
Elango P; Department of Pharmacology, Panimalar Medical College Hospital & Research Institute, Poonamallee, Chennai-600123, Tamil Nadu, India.
L V K S B; Department of Zoology, Guru Ghasidas University, Bilaspur, 495009 (CG), India.

Curr Pharm Des ; 26(37): 4738-4746, 2020.

Article em En | MEDLINE | ID: mdl-32065086

Assuntos

Fármacos Neuroprotetores; Doença de Parkinson; Neurônios Dopaminérgicos; Humanos; Levodopa; Neuroproteção; Fármacos Neuroprotetores/farmacologia; Fármacos Neuroprotetores/uso terapêutico; Doença de Parkinson/tratamento farmacológico

Palavras-chave

Parkinson's disease; biomarkers; clinical trials; electrophysiology; neuroprotection; striatal neurons characterisation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Fármacos Neuroprotetores Tipo de estudo: Screening_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google